Responses to E-cigarette Message Source and Presentation
NCT ID: NCT06274723
Last Updated: 2026-01-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
848 participants
INTERVENTIONAL
2024-11-05
2024-12-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Responses to Message Source and Presentation Using Psychophysiology
NCT06269003
A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status
NCT07038317
Impact of E-Cigarette Prevention Messages on Adolescents
NCT05985538
Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
NCT04740008
Text Messages in Preventing Tobacco Use in Young Adults
NCT03457480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Expert, one-sided
Participants assigned to the expert, one-sidedness condition will receive one-sided e-cigarette messages from an expert source.
Expert, one-sided
Participants will view a brief description of an expert source and see one-sided e-cigarette education messages.
Expert, two-sided
Participants assigned to the expert, two-sidedness condition will receive two-sided e-cigarette messages from an expert source.
Expert, two-sided
Participants will view a brief description of an expert source and see two-sided e-cigarette education messages.
Peer, one-sided
Participants assigned to the peer, one-sidedness condition will receive one-sided e-cigarette messages from a peer source.
Peer, one-sided
Participants will view a brief description of a peer source and see one-sided e-cigarette education messages.
Peer, two-sided
Participants assigned to the peer, two-sidedness condition will receive two-sided e-cigarette messages from a peer source.
Peer, two-sided
Participants will view a brief description of a peer source and see two-sided e-cigarette education messages.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Expert, one-sided
Participants will view a brief description of an expert source and see one-sided e-cigarette education messages.
Expert, two-sided
Participants will view a brief description of an expert source and see two-sided e-cigarette education messages.
Peer, one-sided
Participants will view a brief description of a peer source and see one-sided e-cigarette education messages.
Peer, two-sided
Participants will view a brief description of a peer source and see two-sided e-cigarette education messages.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent in English
* Reporting either vaping in the past 30 days or not having vaped in the past 30 days but susceptible to vaping
Exclusion Criteria
* Not fluent in English
* Not a member of partnering crowdsourcing behavioral research platform conducting the study
18 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Massachusetts, Worcester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Donghee Nicole Lee
Postdoctoral Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donghee N Lee, PhD
Role: PRINCIPAL_INVESTIGATOR
UMass Chan Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMass Chan Medical School
Worcester, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001220
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.